Stem Cells Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
The Stem Cells Market Size accounted for USD 13.0 Billion in 2022 and is projected to achieve a market size of USD 37.8 Billion by 2032 growing at a CAGR of 11.3% from 2023 to 2032.
Report Key Highlights
- Global stem cells market revenue is expected to increase by USD 37.8 Billion by 2032, with a 11.3% CAGR from 2023 to 2032
- North America region led with more than 43% of stem cells market share in 2022
- In 2019, the US National Institutes of Health (NIH) invested over $1.5 billion in stem cell research, making it the largest funder of stem cell research in the world
- The number of clinical trials using stem cells has been increasing steadily over the past decade. In 2020, there were over 5,000 active stem cell trials worldwide
- The National Institutes of Health (NIH) states that stem cells have the potential to treat a wide range of diseases and injuries, including cancer, diabetes, heart disease, and Parkinson's disease
- Rising awareness and acceptance of stem cell therapies, drives the stem cells market size
Stem cells are unique cells in the human body that can differentiate and become any type of cell, whether it is a muscle cell, a bone cell, or a nerve cell. They are primarily found in the embryo and the umbilical cord, but they can also be found in various tissues throughout the body, such as the bone marrow, blood, and fat. Stem cells have enormous potential for medical research and regenerative medicine, as they can be used to treat a wide range of diseases and injuries, such as cancer, diabetes, spinal cord injuries, and heart disease.
The stem cell market has been growing rapidly in recent years due to the increasing prevalence of chronic diseases and the aging population. The rising demand for regenerative medicine, the increasing investment in stem cell research, and the development of innovative technologies are some of the key factors driving the stem cells market growth. The market is expected to continue to grow in the coming years, as stem cell therapies become more widely available and new applications are discovered.
Global Stem Cells Market Trends
Market Drivers
- Rising prevalence of chronic diseases and genetic disorders
- Increasing investment in stem cell research
- Growing demand for regenerative medicine
- Technological advancements in stem cell therapies
- Rising awareness and acceptance of stem cell therapies
Market Restraints
- High cost of stem cell therapies
- Lack of awareness and understanding among patients and healthcare professionals
- Limited availability of stem cell treatments
Market Opportunities
- Emergence of novel technologies for stem cell isolation and purification
- Rise in the number of clinical trials for stem cell therapies
- Potential for stem cell therapies in the treatment of rare diseases
Stem Cells Market Report Coverage
| Market | Stem Cells Market |
| Stem Cells Market Size 2022 | USD 13.0 Billion |
| Stem Cells Market Forecast 2032 | USD 37.8 Billion |
| Stem Cells Market CAGR During 2023 - 2032 | 11.3% |
| Stem Cells Market Analysis Period | 2020 - 2032 |
| Stem Cells Market Base Year | 2022 |
| Stem Cells Market Forecast Data | 2023 - 2032 |
| Segments Covered | By Product, By Application, By Technology, By Therapy, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | STEMCELL Technologies, Inc., Advanced Cell Technology, Inc., Cynata Therapeutics, Osiris Therapeutics, Inc., Human Longevity, Inc., Mesoblast Limited, BIOTIME, Inc., Merck Group, Promethera Biosciences S.A. / N.V., and Takara Bio Group. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Cell therapy is a rapidly growing segment of regenerative medicine. Both immune cell therapy and stem cell therapy make up the cell therapy market. It has been estimated that the global stem cell therapy market will generate a significant amount of revenue by 2032. The growth of the stem cell market is further fuelled by the stupendous success of stem cell treatments in treating chronic diseases such as heart diseases, cancer, and neuromuscular diseases. Increasing funds from private as well as government, rising focus on stem cell research, and a high amount of research on stem cell therapies by various organizations are stimulating the growth of this market.
Factors such as rising awareness towards R&D on stem cells, funding from government and private organizations, and rising awareness towards stem cell therapies are spurring the growth of the global market. There is increased funding for novel stem cell lines, approvals of clinical trials for stem cell therapy, and the development of advanced genomic methods are further propelling the growth of this market. Also, in the emerging markets, there is an increased focus on stem cell research, the evolution of new stem cell therapies, and the development of induced pluripotent stem cells as an alternative to ESCs, thereby giving rise to new opportunities for growth in this market. Moral issues pertaining to embryonic stem cells, lack of adequate infrastructure in emerging countries, and difficulties related to stem cell preservation are hampering the growth of stem cells market value. Also, high costs pertaining to stem cell processing and lack of reimbursements are some major challenges being encountered by the key players in this market.
Stem Cells Market Segmentation
The global stem cells market segmentation is based on product, application, technology, therapy, and geography.
Stem Cells Market By Product
- Adult Stem Cells
- Dental Stem Cells
- Neuronal Stem Cells
- Adipose-derived Stem Cells
- Mesenchymal Stem Cells
- Dedifferentiated fat (DFAT) Cells
- HematopoieticStem Cells
- Umbilical Cord Stem Cells
- Other ASC’s
- Human Embryonic Stem Cells
- Very Small Embryonic Like Stem Cells
- Induced Pluripotent Stem Cells
According to the stem cells industry analysis, the adult stem cells segment accounted for the largest market share in 2022. This growth is due to the increasing demand for cell-based therapies and regenerative medicine. Adult stem cells have several advantages over other types of stem cells, including their accessibility, safety, and ethical acceptability. They also have a lower risk of tumor formation and immune rejection, as they can be derived from the patient's own tissue. Moreover, the growing investments in research and development activities, technological advancements, and the increasing number of clinical trials for adult stem cell therapies are expected to further drive the growth of this segment in the stem cell market.
Stem Cells Market By Application
- Regenerative Medicine
- Oncology
- Hematology
- Neurology
- Injuries
- Liver Disorder
- Incontinence
- Diabetes
- Orthopedics
- Others
- Drug Discovery and development
In terms of applications, the regenerative medicine segment is expected to witness significant growth in the coming years. The growth of the regenerative medicine segment is driven by factors such as the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing investments in research and development activities. Moreover, the growing number of clinical trials for regenerative medicine therapies and the development of innovative technologies are expected to further drive the growth of this segment in the stem cell market. Regenerative medicine has the potential to transform the treatment of various diseases and injuries, such as diabetes, heart disease, and spinal cord injuries.
Stem Cells Market By Technology
- Cryopreservation
- Cell Acquisition
- Bone Marrow Harvest
- Apheresis
- Umbilical Blood Cord
- Cell production
- Isolation
- Therapeutic Cloning
- In-Vitro fertilization
- Cell Culture
- Expansion and Sub-Culture
According to the stem cells market forecast, the cell acquisition segment is expected to witness significant growth in the coming years. The cell acquisition segment includes various techniques for obtaining stem cells, such as bone marrow aspiration, adipose tissue extraction, and peripheral blood stem cell collection. The growth of the cell acquisition segment is driven by factors such as increasing investments in stem cell research, the growing geriatric population, and the rising prevalence of chronic diseases. Moreover, the development of novel technologies for stem cell isolation and purification and the increasing number of clinical trials for stem cell therapies are expected to further drive the growth of this segment in the stem cell market.
Stem Cells Market By Therapy
- Autologous Stem Cell Therapy
- Allogenic Stem Cell Therapy
Based on the therapy, the allogeneic stem cell therapy segment is expected to continue its growth trajectory in the coming years. Allogeneic stem cell therapy has several advantages over autologous stem cell therapy, such as the availability of a larger pool of stem cells, the potential for off-the-shelf therapies, and the lower cost and complexity of treatment. The growth of the allogeneic stem cell therapy segment is driven by factors such as the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for personalized medicine. Moreover, the development of novel technologies for stem cell isolation, purification, and transplantation, and the increasing collaborations and partnerships in the stem cell industry are expected to further drive the growth of this segment in the stem cell market.
Stem Cells Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Stem Cells Market Regional Analysis
North America is currently dominating the global stem cells market, with the United States being the largest market in the region. The region has a highly developed healthcare infrastructure and is home to some of the world's leading stem cell research institutes and biotech companies. Moreover, the presence of a large patient population with chronic diseases and the growing demand for cell-based therapies are driving the growth of the stem cell market in North America. Furthermore, the favorable regulatory environment and supportive government initiatives are also contributing to the growth of the stem cell market in North America. The US FDA has approved several stem cell therapies for the treatment of various diseases, which has further boosted the growth of the market in the region. In addition, the availability of advanced technologies for stem cell research and the increasing investments in stem cell research and development is also driving the growth of the stem cell market in North America.
Stem Cells Market Player
Some of the top stem cells market companies offered in the professional report include STEMCELL Technologies, Inc., Advanced Cell Technology, Inc., Cynata Therapeutics, Osiris Therapeutics, Inc., Human Longevity, Inc., Mesoblast Limited, BIOTIME, Inc., Merck Group, Promethera Biosciences S.A. / N.V., and Takara Bio Group.
Frequently Asked Questions
How big is the stem cells market?
The stem cells market size was USD 13.0 Billion in 2022.
What is the CAGR of the global stem cells market from 2023 to 2032?
The CAGR of stem cells is 11.3% during the analysis period of 2023 to 2032.
Which are the key players in the stem cells market?
The key players operating in the global market are including STEMCELL Technologies, Inc., Advanced Cell Technology, Inc., Cynata Therapeutics, Osiris Therapeutics, Inc., Human Longevity, Inc., Mesoblast Limited, BIOTIME, Inc., Merck Group, Promethera Biosciences S.A. / N.V., and Takara Bio Group.
Which region dominated the global stem cells market share?
North America held the dominating position in stem cells industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of stem cells during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global stem cells industry?
The current trends and dynamics in the stem cells industry include rising prevalence of chronic diseases and genetic disorders, and increasing investment in stem cell research.
Which product held the maximum share in 2022?
The adult stem cells product held the maximum share of the stem cells industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
